RemeGen Biosciences
RemeGen Biosciences is dedicated to creating innovative medicines for patients suffering from serious illnesses, focusing on the discovery and development of therapeutics for diseases with unmet medical needs. They leverage deep insights into human biology, advanced protein engineering, and rich experience in manufacturing and clinical development to uncover novel therapeutic targets and develop best-in-class and first-in-class biotherapeutics.
Industries
Nr. of Employees
small (1-50)
RemeGen Biosciences
650 Gateway Blvd. #110, South San Francisco, CA 94080
Products
Biologics for Oncology
RemeGen Biosciences develops biologics targeting cancer treatment, focusing on innovative therapeutic molecules including antibodies and multi-specificity modalities.
Biologics for Autoimmune Diseases
The company creates biologics aimed at treating autoimmune diseases, leveraging advanced protein engineering and design technologies.
Biologics for Ophthalmic Diseases
RemeGen Biosciences also focuses on developing biologics for ophthalmic diseases, utilizing their expertise in protein engineering.
Clinical Trials Management
RemeGen Biosciences manages clinical trials, ensuring compliance with protocols and regulations, and overseeing trial materials and data integrity.
Therapeutic Technology Development
The company develops novel therapeutic molecules, emphasizing protein characterization and mass spectrometry techniques.
Clinical Supply Chain Management
RemeGen Biosciences manages the clinical supply chain, including procurement, packaging, and distribution of clinical trial materials.
Biologics for Oncology
RemeGen Biosciences develops biologics targeting cancer treatment, focusing on innovative therapeutic molecules including antibodies and multi-specificity modalities.
Biologics for Autoimmune Diseases
The company creates biologics aimed at treating autoimmune diseases, leveraging advanced protein engineering and design technologies.
Biologics for Ophthalmic Diseases
RemeGen Biosciences also focuses on developing biologics for ophthalmic diseases, utilizing their expertise in protein engineering.
Clinical Trials Management
RemeGen Biosciences manages clinical trials, ensuring compliance with protocols and regulations, and overseeing trial materials and data integrity.
Therapeutic Technology Development
The company develops novel therapeutic molecules, emphasizing protein characterization and mass spectrometry techniques.
Clinical Supply Chain Management
RemeGen Biosciences manages the clinical supply chain, including procurement, packaging, and distribution of clinical trial materials.
Services
Target identification, antibody and multispecific modality design, in vitro screening and lead optimization for oncology and autoimmune indications.
Design and execution of animal efficacy and PK/PD studies, biomarker identification and translational analysis.
LC-MS/MS, peptide mapping, intact and reduced protein analyses, and proteomics workflows for therapeutic molecule characterization.
Protocol development, site monitoring, EDC/clinical database management, data cleaning and database lock activities to support clinical trials.
eCTD module authoring, CMC dossier preparation, submission strategy and agency interaction support for INDs, BLAs and similar applications.
Clinical supply forecasting, packaging/labeling oversight, distribution logistics, and IRT/IXRS configuration and UAT for global trials.
Target identification, antibody and multispecific modality design, in vitro screening and lead optimization for oncology and autoimmune indications.
Design and execution of animal efficacy and PK/PD studies, biomarker identification and translational analysis.
LC-MS/MS, peptide mapping, intact and reduced protein analyses, and proteomics workflows for therapeutic molecule characterization.
Protocol development, site monitoring, EDC/clinical database management, data cleaning and database lock activities to support clinical trials.
eCTD module authoring, CMC dossier preparation, submission strategy and agency interaction support for INDs, BLAs and similar applications.
Clinical supply forecasting, packaging/labeling oversight, distribution logistics, and IRT/IXRS configuration and UAT for global trials.
Expertise Areas
- Biologics discovery and protein engineering
- Preclinical in vivo pharmacology and translational PK/PD
- Analytical characterization and mass spectrometry
- Clinical trial management and site monitoring
Key Technologies
- LC-MS/MS
- Peptide mapping
- Proteomics workflows
- Flow cytometry